$0
Senior Vice President, CLO, Sec./Dir. (Until 12/21)
2021
Senior Vice President, CLO, Sec./Dir. (Until 12/21) at Cystic Fibrosis Foundation Therapeutics Inc.
Fiscal year ended December 31, 2021. Published on January 25, 2026.
Total compensation
Chris Gegelys has been listed as an employee of Cystic Fibrosis Foundation Therapeutics Inc. in Form 990 filings since fiscal year 2019.